Vivace Therapeutics
San Mateo, CA · Founded 2014 · CIK 0001630575 · Biotech · Private
Novel small molecule oncology therapeutics
vivacetherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $61M
- 4 Form D · Mar 2025
- 19 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 7 granted · 33 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,050,000 | |
| Private capital raised | Form D · SEC | $8,000,008 | |
| Private capital raised | Form D · SEC | $29,999,993 | |
| Private capital raised | Form D · SEC | $17,499,997 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2308 | Synlico Inc. | — | $5.2M |
| 2309 | Humonix Biosciences Inc | — | — |
| 2310 | Deep Origin Inc. | — | $29M |
| 2311 | Vivace Therapeutics | — | $61M |
| 2312 | Volta Labs, Inc. | — | $29M |
| 2313 | FabricNano Inc. | — | $21M |
| 2314 | HALO BIOSCIENCES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sheng DingExecutive Officer
- Edward HuDirector
- Leonard PostDirector · Executive Officer
- Shuang QiaoDirector · Executive Officer
- Tim ShannonDirector
- Jake SimsonDirector
- Jun WuDirector
- Chenguang ZhouDirector
Patents
- Bicyclic Compoundsgranted
- Tertiary Carboxamide Compoundsapplication
- Bicyclic Compoundsgranted
- Oxadiazole Compoundsgranted
- Heteroaryl Compoundsapplication
- Benzocarbonyl Compoundsgranted
- Bicyclic Compoundsgranted
- Benzosulfonyl Compoundsgranted
- Non-fused Tricyclic Compoundsgranted
- Compounds For Modulating Yap-tead/hippo Pathwayapplication
- Compounds And Methods For Treating Cancerapplication
- Pharmaceutical Formulations And Dosing Schedules Of A Yap/taz-tead Inhibitorapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.